Sunnyvale, Calif. – September 11, 2026 -- Anitoa Systems, LLC. has integrated cloud connectivity and enterprise-grade security into its portable qPCR molecular testing instruments, enabling remote operation and centralized data aggregation for disease surveillance.
Remote access replaces physical tethering to diagnostic hardware
Users can now control Anitoa's qPCR devices via a secure HTTPS interface through a cross-platform web application, allowing remote data collection, experiment setup, and real-time monitoring from any location. The shift removes the requirement that operators remain physically present with field-deployed instruments.
Centralized data feeds support AI-driven outbreak detection
The cloud architecture routes diagnostic data into large-scale analytics platforms, letting health organizations aggregate results across multiple testing sites simultaneously. Anitoa positions this as critical infrastructure for continuous biosurveillance, enabling identification of emerging pathogen trends and faster, coordinated outbreak responses.
Hardware root of trust secures patient data at collection point
To address data privacy risks inherent in networked diagnostic devices, Anitoa embedded a dedicated hardware security root of trust module within each instrument's electronics subsystem. The company says this makes devices tamper-proof and physically un-clonable, with encryption applied from the moment of data collection through cloud transmission.
Cloud upgrade builds on CMOS sensor-based portable testing platform
Anitoa's qPCR instruments rely on the company's proprietary ultra-low-light CMOS bioimaging sensor, which the firm markets as an alternative to traditional photon-multiplier tube and CCD optics used in laboratory-based molecular testing. The sensor technology underpins the devices' low power consumption and calibration-free design, which Anitoa has marketed for decentralized testing outside conventional laboratory settings.